![](/images/general/no_picture/200_user.png)
Phung Hoang Joseph Nguyen
Examiner (ID: 4727, Phone: (571)270-1949 , Office: P/2656 )
Most Active Art Unit | 2656 |
Art Unit(s) | 2651, 2614, 4183, 2691, 2656 |
Total Applications | 1081 |
Issued Applications | 835 |
Pending Applications | 78 |
Abandoned Applications | 168 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18649452
[patent_doc_number] => 20230295265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => Pocket Engineering of HLA Alleles for Treating Autoimmunity
[patent_app_type] => utility
[patent_app_number] => 18/156887
[patent_app_country] => US
[patent_app_date] => 2023-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18156887
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/156887 | Pocket Engineering of HLA Alleles for Treating Autoimmunity | Jan 18, 2023 | Pending |
Array
(
[id] => 18294465
[patent_doc_number] => 20230104151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => A METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS
[patent_app_type] => utility
[patent_app_number] => 17/979437
[patent_app_country] => US
[patent_app_date] => 2022-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17979437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/979437 | A METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS | Nov 1, 2022 | Abandoned |
Array
(
[id] => 18351363
[patent_doc_number] => 20230139474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => RNA TARGETING OF MUTATIONS VIA SUPPRESSOR tRNAs AND DEAMINASES
[patent_app_type] => utility
[patent_app_number] => 17/822338
[patent_app_country] => US
[patent_app_date] => 2022-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822338
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822338 | RNA TARGETING OF MUTATIONS VIA SUPPRESSOR tRNAs AND DEAMINASES | Aug 24, 2022 | Abandoned |
Array
(
[id] => 18140036
[patent_doc_number] => 20230013874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => CHIMERIC ANTIGEN RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 17/751266
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/751266 | CHIMERIC ANTIGEN RECEPTOR | May 22, 2022 | Pending |
Array
(
[id] => 18270015
[patent_doc_number] => 20230091257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => Pocket Engineering of HLA Alleles for Treating Autoimmunity
[patent_app_type] => utility
[patent_app_number] => 17/744554
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744554 | Pocket Engineering of HLA Alleles for Treating Autoimmunity | May 12, 2022 | Pending |
Array
(
[id] => 18451530
[patent_doc_number] => 20230192808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => HLA ENGINEERING METHODS AND COMPOSITIONS FOR TREATMENT OF AUTOIMMUNITY
[patent_app_type] => utility
[patent_app_number] => 17/741438
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17741438
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/741438 | HLA ENGINEERING METHODS AND COMPOSITIONS FOR TREATMENT OF AUTOIMMUNITY | May 9, 2022 | Pending |
Array
(
[id] => 18142790
[patent_doc_number] => 20230016634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => CATIONIC DENDRIMERS FOR THE CULTURE OF ADHERENT CELLS
[patent_app_type] => utility
[patent_app_number] => 17/724038
[patent_app_country] => US
[patent_app_date] => 2022-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17724038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/724038 | CATIONIC DENDRIMERS FOR THE CULTURE OF ADHERENT CELLS | Apr 18, 2022 | Pending |
Array
(
[id] => 17944344
[patent_doc_number] => 20220331361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => GENE TRANSFER VECTORS AND METHODS OF ENGINEERING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/714873
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714873
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714873 | GENE TRANSFER VECTORS AND METHODS OF ENGINEERING CELLS | Apr 5, 2022 | Pending |
Array
(
[id] => 17927523
[patent_doc_number] => 20220322648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => GENETICALLY MODIFIED MICE COMPRISING HUMANIZED CELLULAR IMMUNE SYSTEM COMPONENTS WITH IMPROVED DIVERSITY OF TCRB REPERTOIRE
[patent_app_type] => utility
[patent_app_number] => 17/709150
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17709150
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/709150 | GENETICALLY MODIFIED MICE COMPRISING HUMANIZED CELLULAR IMMUNE SYSTEM COMPONENTS WITH IMPROVED DIVERSITY OF TCRB REPERTOIRE | Mar 29, 2022 | Pending |
Array
(
[id] => 17830401
[patent_doc_number] => 20220267705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => CO-CULTURE APPARATUS, CO-CULTURE SYSTEM, AND CO-CULTURE METHOD
[patent_app_type] => utility
[patent_app_number] => 17/679247
[patent_app_country] => US
[patent_app_date] => 2022-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679247
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/679247 | CO-CULTURE APPARATUS, CO-CULTURE SYSTEM, AND CO-CULTURE METHOD | Feb 23, 2022 | Pending |
Array
(
[id] => 18497684
[patent_doc_number] => 20230220353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => IN VITRO LIVER ORGANOIDS AND MINI-BILE DUCT MODELS OF BILIARY ARTRESIA AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/573371
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573371 | IN VITRO LIVER ORGANOIDS AND MINI-BILE DUCT MODELS OF BILIARY ARTRESIA AND APPLICATIONS THEREOF | Jan 10, 2022 | Pending |
Array
(
[id] => 17702856
[patent_doc_number] => 20220202862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => CD8 POLYPEPTIDES, COMPOSITIONS, AND METHODS OF USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/563599
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17563599
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/563599 | CD8 POLYPEPTIDES, COMPOSITIONS, AND METHODS OF USING THEREOF | Dec 27, 2021 | Pending |
Array
(
[id] => 17685842
[patent_doc_number] => 20220193134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => CO-USE OF LENALIDOMIDE WITH CAR-T CELLS
[patent_app_type] => utility
[patent_app_number] => 17/559355
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27905
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17559355
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/559355 | CO-USE OF LENALIDOMIDE WITH CAR-T CELLS | Dec 21, 2021 | Abandoned |
Array
(
[id] => 18434352
[patent_doc_number] => 20230181646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => METHOD OF PRODUCTION OF SPECIALIZED EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 17/550431
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17550431
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/550431 | METHOD OF PRODUCTION OF SPECIALIZED EXOSOMES | Dec 13, 2021 | Abandoned |
Array
(
[id] => 17655369
[patent_doc_number] => 20220175834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHODS FOR CULTURING IMMUNE CELLS
[patent_app_type] => utility
[patent_app_number] => 17/456374
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17456374
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/456374 | METHODS FOR CULTURING IMMUNE CELLS | Nov 22, 2021 | Pending |
Array
(
[id] => 17641949
[patent_doc_number] => 20220169687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS
[patent_app_type] => utility
[patent_app_number] => 17/523431
[patent_app_country] => US
[patent_app_date] => 2021-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17523431
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/523431 | METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS | Nov 9, 2021 | Abandoned |
Array
(
[id] => 17520712
[patent_doc_number] => 20220106561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => NERVE BUNDLE AND PRODUCTION METHOD OF NERVE BUNDLE
[patent_app_type] => utility
[patent_app_number] => 17/478271
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478271
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/478271 | NERVE BUNDLE AND PRODUCTION METHOD OF NERVE BUNDLE | Sep 16, 2021 | Pending |
Array
(
[id] => 17426931
[patent_doc_number] => 20220054639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => In-situ stable injectable collagen-based hydrogels for cell and growth factor delivery
[patent_app_type] => utility
[patent_app_number] => 17/410554
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/410554 | In-situ stable injectable collagen-based hydrogels for cell and growth factor delivery | Aug 23, 2021 | Pending |
Array
(
[id] => 17428707
[patent_doc_number] => 20220056415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => MODIFIED MESENCHYMAL STEM CELL CULTURE MEDIUM, BONE MARROW MESENCHYMAL STEM CELLS AND CULTURE METHODS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/404826
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17404826
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/404826 | MODIFIED MESENCHYMAL STEM CELL CULTURE MEDIUM, BONE MARROW MESENCHYMAL STEM CELLS AND CULTURE METHODS AND USE THEREOF | Aug 16, 2021 | Pending |
Array
(
[id] => 17385919
[patent_doc_number] => 20220033771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => Combination Treatment Of Induced Pluripotent Stem Cells Using Interleukins
[patent_app_type] => utility
[patent_app_number] => 17/392620
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392620
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/392620 | Combination Treatment Of Induced Pluripotent Stem Cells Using Interleukins | Aug 2, 2021 | Pending |